Annual Report

Overview

The report presents Glenmark's FY2019-20 response to COVID-19, including continuity measures and India's first approved oral antiviral Favipiravir (FabiFlu). It highlights community relief, including a pledge of over 5 million meals in India, alongside CSR programs spanning child health, healthcare access and sustainable livelihoods. The report also describes renewable-energy, emissions-reduction and waste-management initiatives.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2019
Period: 1 April 2019 – 31 March 2020
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services